A. S. Deyneka

A. S. Deyneka

Auto-generated profile, based on publicly available information

A. S. Deyneka

Specialized Medical College of Municipal Institution of Higher Education «Rivne Medical Academy» ; Municipal Institution of Higher Education «Rivne Medical Academy» of Rivne Region Council

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2024 in ScienceRise: Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
TSTetiana Solominchuk
Tetiana Solominchuk
VRVitalii Rudiuk
Vitalii Rudiuk
NSNataliia Smielova
Nataliia Smielova
ADAlina Deyneka
Alina Deyneka
TNTetiana Nesteruk
Tetiana Nesteruk
VGVictoriya A. Georgiyants
Victoriya A. Georgiyants
The aim: development of the technology for obtaining the base of xylometazoline, suitable for the development of formulations in combination with essential oils. Development and validation of methods of control of related substances and assay of the obtained base of xylometazoline. Study of the stability of the obtained xylometazoline base under long-term and accelerated conditions. Materials and methods: experimental samples of xylometazoline base were obtained from commercially available xylometazoline hydrochloride and aqueous sodium hydroxide solution. The quality control of the obtained substance was carried out in accordance with the requirements of the internal specification. The analysis of raw materials of xylometazoline hydrochloride was carried out in accordance with the monograph of the European Pharmacopoeia on xylometazoline hydrochloride (Ph. Eur. 10.1, 1162 (01/2008)). Results: a technology for obtaining xylometazoline base from xylometazoline hydrochloride by the action of a 2 % solution of a strong base, namely sodium hydroxide, was developed. Developed and validated methods of quality control of the obtained xylometazoline base according to indicators of related substances and assay. The stability of the substance was studied for 1 year; the results of control under accelerated research conditions meet the requirements of the specification, which allows for establishing a shelf life of 2 years. Conclusions: the technology for obtaining xylometazoline base and quality control methods based on the monograph of the European Pharmacopoeia on xylometazoline hydrochloride was developed. The developed technology ensures the proper quality of the substance in accordance with the requirements of the internal specification. Analytical methods "related substances" and "assay" meet the established criteria during validation. The obtained results were later used to develop a medicine based on xylometazoline and eucalyptus oil – Eukazolin, nasal drops

1 December 2022 in Current Issues in Pharmacy and Medical Sciences
Verified
Journal Article
Open access
PDF file
ADAlina Deyneka
Alina Deyneka
VPViktoriia Protska
Viktoriia Protska
IZIryna Zhuravel
Iryna Zhuravel
OKOleksandra Kyslychenko
Oleksandra Kyslychenko
Cockscomb (Сelosia cristata (L.) Kuntze) is a well-known decorative plant belonging to the Amaranthaceae L. family. It is used in South East Asia folk medicine as an anesthetic, anti-microbial, hemostatic, tonic and anti-inflammatory drug. Some 11 to 12 fatty acids have been identified in cockscomb roots, leaves, stem, herb, flowers and seeds, and their quantitative content has been determined by gas chromatography. Accordingly, in all herb samples, unsaturated fatty acids dominated, forming 68.18 to 75.93% of total content. Mostly, these compounds were accumulated in the roots. Among the unsaturated fatty acids, linoleic acid prevailed in roots, stems, herb, flowers and seeds, whereas linolenic acid prevailed in the leaves. The highest content of linoleic acid (45.57±1.14%) was found in the seeds, while that of linolenic acid (53.63±0.53%) was found in the leaves. The obtained results will be applied in the development of drugs on the basis of cockscomb herb lipophilic fraction.

1 June 2021 in Current issues in pharmacy and medicine: science and practice
Verified
Journal Article
Open access
PDF file
ADA. S. Deyneka
A. S. Deyneka
VPV. V. Protska
V. V. Protska
IZI. O. Zhuravel
I. O. Zhuravel
OKO. A. Kyslychenko
O. A. Kyslychenko
VKV. Yu. Kuznietsova
V. Yu. Kuznietsova
Cockscomb (Сelosia cristata (L.) Kuntze) is grown in Ukraine mostly as a decorative plant. According to literature, it contains phenolic, terpenic, steroid, and nitrogen-containing compounds, showing a large range of biological activity. The aim of the work was to study qualitative composition and determination of quantitative content of mineral elements in cockscomb roots, stems, leaves, flowers, and seeds. Materials and methods. The mineral composition of cockscomb raw material was studied by atomic absorption spectroscopy. Results. In cockscomb roots, stems, leaves, flowers, and seeds 19 mineral elements were identified and determined. The bulk of mineral elements was accumulated in cockscomb leaves – 11580.54 ± 289.51 μg/100 g. In all samples of the herb potassium dominated within the limits of 1125.00 ± 28.12 μg/100 g to 7000.00 ± 175.00 μg/100 g. Prevailing microelements were iron in plant roots and seeds (210.00 ± 5.25 μg/100 g and 81.00 ± 2.02 μg/100 g respectively), aluminum in leaves and flowers (215.00 ± 2.25 μg/100 g and 44.00 ± 1.10 μg/100 g respectively), zinc in stems (5.70 ± 0.14 μg/100 g). Besides, such microelements as zinc (53.00 ± 1.33 μg/100 g) and strontium (21.20 ± 0.53 μg/100 g) were mostly accumulated in roots, manganese (27.00 ± 0.68 μg/100 g) in leaves, copper (2.00 ± 0.05 μg/100 g) in flowers. The content of heavy metals was within the limits stipulated in Ukrainian Pharmacopoeia. Conclusions. The obtained results will be used in the standardization of cockscomb raw material and in the development of medicines on the basis of this raw material.

17 November 2023 in Social Pharmacy in Health Care
Verified
Journal Article
Open access
PDF file
OSO. V. Shtrimaitis
O. V. Shtrimaitis
Oleksandr KukhtenkoOleksandr Kukhtenko
Oleksandr Kukhtenko
ADA. S. Deyneka
A. S. Deyneka
Aim. To analyze the use of retinoid-containing products in pharmaceutical and cosmetic practices in Ukraine and determine the prospects for developing domestic products with retinoids. Materials and methods. The study employed such methods as surveys, mathematical statistics, data synthesis, and interpretation. The study object was senior students of higher pharmaceutical education, pharmacy employees (pharmacists), cosmetic industry professionals (dermatologists, cosmetologists), and visitors to beauty salons. The study was conducted from June to July 2023, during the russian military aggression. Internet surveys were used to interact with the target audience, including students of the National University of Pharmacy (Kharkiv) and the Municipal Institution of Higher Education “Rivne Medical Academy” (Rivne). Graduates of these educational institutions working in the cosmetic and pharmaceutical sectors, as well as professionals in the cosmetic industry and salon staff, were surveyed. A simplified formula for calculating a simple probability sample during public opinion surveys was used. The survey results obtained show the researched reality within the usual measure of reliability. Results. Based on the research results, the level of awareness regarding the use of pharmaceutical and cosmetic products with retinoids by both consumers and the key players of the retinoid-containing product market, including dermatologists, cosmetologists, and pharmacy workers, has been determined. The main advantages and disadvantages of using retinoid-containing products, the approaches of different respondent groups in choosing cosmetic/pharmaceutical products with retinoids, and consumer preferences and recommendations of pharmaceutical and cosmetic market experts have been identified. It has been found that adapalene, tretinoin, and isotretinoin are the most well-known among all retinoids used at the pharmaceutical and cosmetic markets in Ukraine. For the treatment of acne and psoriasis, the majority of respondents prefer pharmaceutical products (52.8 % and 72 %, respectively). In contrast, a significant percentage of respondents in all groups are ready to use cosmetic products for skin rejuvenation procedures. Conclusions. The data obtained show the need to develop a domestic pharmaceutical product based on retinoids for the treatment of acne, psoriasis, rosacea, and keratosis. The composition and technology of the product developed should ensure minimal side effects while maintaining high therapeutic activity.